James R Perry

James R Perry

UNVERIFIED PROFILE

Are you James R Perry?   Register this Author

Register author
James R Perry

James R Perry

Publications by authors named "James R Perry"

Are you James R Perry?   Register this Author

33Publications

770Reads

48Profile Views

Procarbazine, CCNU and vincristine (PCV) versus temozolomide chemotherapy for patients with low-grade glioma: a systematic review.

Oncotarget 2018 Sep 14;9(72):33623-33633. Epub 2018 Sep 14.

Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.25890DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154749PMC
September 2018

Hospitalizations in elderly glioblastoma patients.

Ann Palliat Med 2017 Dec 11;6(Suppl 2):S161-S169. Epub 2017 Aug 11.

Odette Cancer Centre, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/apm.2017.06.02DOI Listing
December 2017

Optimal Therapies for Newly Diagnosed Elderly Patients with Glioblastoma.

Curr Treat Options Oncol 2017 10 27;18(11):66. Epub 2017 Oct 27.

Division of Neurology, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, Toronto, ON, M4N 3M5, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-017-0508-7DOI Listing
October 2017

Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG.

Neuro Oncol 2017 Aug;19(8):1119-1126

Tel-Aviv Sourasky Medical Center, Tel-Aviv University; European Organization for Research and Treatment of Cancer, Brussels (EORTC); National Institutes of Health (M.R.M.); University of Alabama at Birmingham; Princess Margaret Cancer Centre, University of Toronto; Lausanne University Hospital; NRG Oncology Statistics and Data Management Center; Odette Cancer Centre and Sunnybrook Health Sciences Centre, University of Toronto; Samsung Medical Center, Sungkyunkwan University School of Medicine; Edinburgh Cancer Centre; Mayo Clinic; Robert-Janker Clinic at the University of Bonn Medical Centre, and MAASTRO clinic, GROW School for Oncology, Maastricht University Medical Centre; Miami Cancer Institute; Erasmus University Hospital; Dana-Farber Cancer Institute and Harvard Medical School; University of Zurich.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nox025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570239PMC
August 2017

Radiation plus Temozolomide in Patients with Glioblastoma.

N Engl J Med 2017 06;376(22):2197

University of Toronto, Toronto, ON, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1704726DOI Listing
June 2017

Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma.

N Engl J Med 2017 03;376(11):1027-1037

From Odette Cancer Centre, Sunnybrook Health Sciences Centre (J.R.P., A.S.) and Princess Margaret Cancer Centre (N.L., W.P.M.), Toronto, the Canadian Cancer Trials Group, Queens University, Kingston, ON (C.J.O., C.W., K.D.), University of Calgary, Calgary, AB (J.G.C.), University of Alberta, Edmonton (W.R.), Quality of Life Consulting, West Vancouver, BC (D.O.), Queen's University, Kingston General Hospital, Kingston, ON (J.P.R.), and Juravinski Cancer Centre, Hamilton, ON (H.H.) - all in Canada; Azienda Unità Sanitaria Locale- Istituto di Ricovero e Cura a Carattere Scientifico Istituto delle Scienze Neurologiche, Bologna (A.A.B., E.F.), and Fondazione Istituto Neurologico Carlo Besta, Milan (L. Fariselli) - both in Italy; University Hospital Gasthuisberg, Leuven, Belgium (J.M.); Peter MacCallum Cancer Centre, Melbourne, VIC (C.P.), University of Newcastle, Newcastle, NSW (M.F.), University of Queensland, Brisbane (M.F.), and Royal North Shore Hospital, Sydney (M.B.) - all in Australia; Saitama Medical University International Medical Center, Saitama, Japan (R.N.); Hôpital de la Pitié-Salpêtrière (F.L.-D., L. Feuvret), Paris, and Aix-Marseille University, Assistance Publique-Hôpitaux de Marseille, Centre Hospitalier Universitaire Timone, Marseilles (O.C.) - both in France; the European Organization for Research and Treatment of Cancer, Brussels (V.G.); the Neurology Clinic, University of Heidelberg, Heidelberg, Germany (A.W., W.W.); Tauranga Hospital, Tauranga, New Zealand (M.T.); and Maastricht University Medical Center and School for Oncology and Developmental Biology, Maastricht, the Netherlands (B.G.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1611977DOI Listing
March 2017

Vascular complications in glioma patients.

Handb Clin Neurol 2016 ;134:251-66

Division of Neurology, Odette Cancer Centre and Sunnybrook Health Science Centre, University of Toronto, Toronto, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/B978-0-12-802997-8.00015-3DOI Listing
December 2016

Glioblastoma in the elderly: making sense of the evidence.

Neurooncol Pract 2016 Jun 1;3(2):77-86. Epub 2015 Sep 1.

Department of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada (M.M., N.L.); Neurology Clinic and National Center for Tumor Disease and Neurology Clinic, Heidelberg University Medical Center and DKFZ, Heidelberg, Germany (W.W); Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA(D.A.R.); Department of Advanced Home Care and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden (A.M.); Department of Medical Oncology, Prince of Wales Hospital, Randwick NSW, Australia (E.H.); Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, Zürich, Switzerland (M.W.); Division of Neurology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada (J.R.P.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nop/npv027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668261PMC
June 2016

Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma.

J Clin Oncol 2016 Mar 19;34(7):731-9. Epub 2016 Jan 19.

Caroline Happold, Patrick Roth, Roger Stupp, and Michael Weller, University Hospital Zurich; Monika Hegi, University Hospital Lausanne, Switzerland; Thierry Gorlia, EORTC Data Centre, Brussels, Belgium; Olivier Chinot, Aix-Marseille University, Marseille, France; Mark R. Gilbert, The University of Texas MD Anderson Cancer Center, Houston, TX; L. Burt Nabors, University of Alabama at Birmingham, Birmingham, AL; Wolfgang Wick, University of Heidelberg & German Cancer Research Center, Heidelberg, Germany; Stephanie L. Pugh, NRG Oncology Statistics and Data Management Center, Philadelphia, PA; Timothy Cloughesy, UCLA Neuro-Oncology Program, Los Angeles, CA; David A. Reardon, Dana-Farber Cancer Institute, Boston, MA; James R. Perry, University of Toronto, Toronto, Ontario, Canada; and Minesh P. Mehta, University of Maryland, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.6563DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070573PMC
March 2016

Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study.

Neuro Oncol 2015 May 11;17(5):708-17. Epub 2015 Mar 11.

University of Alabama at Birmingham, Birmingham, Alabama (L.B.N.); Baylor University Medical Center, Dallas, Texas (K.L.F.); Henry Ford Hospital, Detroit, Michigan (T.M.); Clinic for Neurosurgery, Clinical Center of Serbia, Medical Faculty University of Belgrade, Belgrade, Serbia (D.G.); Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology Gliwice Branch, Radiotherapy and Chemotherapy Clinic, Gliwice, Poland (R.T.); Samsung Medical Center, Seoul, South Korea (D.H.N.); Centrum Onkologii Ziemi Lubelskiej, Lublin, Poland (M.M.); St. Luke's Brain Tumor Center, St. Luke's Hospital, Kansas City, Missouri (M.S.); Barrow Neurological Institute, Phoenix, Arizona (L.A.); Medical Oncology Unit 1, IOV, IRCCS, Padova, Italy (V.Z.); Policlinico di Modena, Modena, Italy (R.D.); Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (J.R.P.); Merck KGaA, Darmstadt, Germany (C.H., M.P.); Department of Clinical Neurosciences, University Hospital Lausanne, Lausanne, Switzerland (M.E.H.); Institute of Pathology, University Hospital Lausanne, Lausanne, Switzerland (B.L.); Dana-Farber Cancer Institute, Boston, Massachusetts (D.A.R.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou356DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482861PMC
May 2015

Phase I/randomized phase II study of afatinib, an irreversible ErbB family blocker, with or without protracted temozolomide in adults with recurrent glioblastoma.

Neuro Oncol 2015 Mar 19;17(3):430-9. Epub 2014 Aug 19.

Dana-Farber Cancer Institute, Boston, Massachusetts (D.A.R.); University of Alabama, Birmingham, Alabama (L.B.N.); Princess Margaret Hospital, Toronto, Ontario, Canada (W.P.M.); Odette Cancer Centre, University of Toronto, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (J.R.P.); Barrow Neurological Institute, Phoenix, Arizona (W.S.); Department of Medical Oncology, McGill University, Montréal, Quebec, Canada (P.K.); Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada (D.M.); Johnnie Cochran Brain Tumor Center, Cedars-Sinai Medical Center, Los Angeles, California (S.P., A.C.); Boehringer Ingelheim R.C.V GmbH & Co KG, 1120 Vienna, Austria (A.C.); Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut (Y.F., J.C.); Boehringer Ingelheim Pharma GmbH & Co. K.G., 88400 Biberach, Germany (S.S.W.); CancerCare Manitoba, Winnipeg, Manitoba, Canada (D.D.E.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou160DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483093PMC
March 2015

Glioblastoma: If this is the "Temozolomide Era" Where is the Evidence?

Authors:
James R Perry

Can J Neurol Sci 2014 May;41(3):301-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/s0317167100017236DOI Listing
May 2014

Comparison of multiple adjuvants on the stability and immunogenicity of a clade C HIV-1 gp140 trimer.

Vaccine 2014 Apr 18;32(18):2109-16. Epub 2014 Feb 18.

Center for Virology & Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA; Ragon Institute of MGH, MIT and Harvard, Boston, MA 02114, USA. Electronic address:

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980048PMC
http://dx.doi.org/10.1016/j.vaccine.2014.02.001DOI Listing
April 2014

Thrombosis in brain tumors.

Semin Thromb Hemost 2014 Apr 5;40(3):325-31. Epub 2014 Mar 5.

Division of Neurology, Sunnybrook Health Science and Odette Cancer Centre, University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0034-1370791DOI Listing
April 2014

Optimal management of elderly patients with glioblastoma.

Cancer Treat Rev 2013 Jun 19;39(4):350-7. Epub 2012 Jun 19.

Department of Radiation Oncology, Princess Margaret Hospital/University Health Network, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2012.05.008DOI Listing
June 2013

Standards of care for treatment of recurrent glioblastoma--are we there yet?

Neuro Oncol 2013 Jan 7;15(1):4-27. Epub 2012 Nov 7.

Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, CH-8091 Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nos273DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534423PMC
January 2013

Thromboembolic disease in patients with high-grade glioma.

Authors:
James R Perry

Neuro Oncol 2012 Sep;14 Suppl 4:iv73-80

Division of Neurology and Odette Cancer Centre, University of Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nos197DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480243PMC
September 2012

Glioblastoma: patterns of recurrence and efficacy of salvage treatments.

Can J Neurol Sci 2011 Jul;38(4):621-5

Divison of Neurology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/s0317167100012166DOI Listing
July 2011

Advances in malignant glioma drug discovery.

Expert Opin Drug Discov 2011 Jul 7;6(7):739-53. Epub 2011 Jun 7.

Duke University Medical Center , The Preston Robert Tisch Brain Tumor Center at Duke , Departments of Surgery and Pediatrics , Box 3624, Durham, NC 27710 , US +1 919 668 2650 ; +1 919 668 2485 ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/17460441.2011.584530DOI Listing
July 2011

Anticoagulation of malignant glioma patients in the era of novel antiangiogenic agents.

Authors:
James R Perry

Curr Opin Neurol 2010 Dec;23(6):592-6

Odette Cancer Centre, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WCO.0b013e32833feb73DOI Listing
December 2010

A citywide prehospital protocol increases access to stroke thrombolysis in Toronto.

Stroke 2009 Dec 29;40(12):3841-4. Epub 2009 Oct 29.

North and East GTA-Ontario Regional Stroke Centre and Division of Neurology, Department of Medicine, and Brain Sciences Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://stroke.ahajournals.org/content/40/12/3841.full.pdf
Web Search
http://stroke.ahajournals.org/cgi/doi/10.1161/STROKEAHA.108.
Publisher Site
http://dx.doi.org/10.1161/STROKEAHA.108.540377DOI Listing
December 2009

Recurrent PNET with MGMT methylation responds to temozolomide.

Can J Neurol Sci 2009 Sep;36(5):654-7

Divison of Neurology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/s0317167100008209DOI Listing
September 2009

Temozolomide rechallenge in recurrent malignant glioma by using a continuous temozolomide schedule: the "rescue" approach.

Cancer 2008 Oct;113(8):2152-7

Crolla Family Brain Tumour Research Unit, Department of Medicine, Sunnybrook Health Sciences Center, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.23813DOI Listing
October 2008

Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation.

J Neurooncol 2006 Jul 25;78(3):295-302. Epub 2006 Apr 25.

Department of Neuro-Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11060-005-9098-5
Publisher Site
http://dx.doi.org/10.1007/s11060-005-9098-5DOI Listing
July 2006

Bony metastases of anaplastic oligodendroglioma respond to temozolomide.

Can J Neurol Sci 2004 Feb;31(1):102-8

Division of Neurology, Crolla Family Brain Tumour Research Unit, Sunnybrook and Women's College Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/s0317167100002912DOI Listing
February 2004

Glioma therapies: how to tell which work?

J Clin Oncol 2003 Oct 11;21(19):3547-9. Epub 2003 Aug 11.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2003.05.885DOI Listing
October 2003

Carotid artery stenosis.

Postgrad Med 1994 Nov;96(5):61-72

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00325481.1994.11945907DOI Listing
November 1994